Effect of Antimicrobial Locks for Tunneled Hemodialysis Catheters on Bloodstream Infection and Bacterial Resistance: A Quality Improvement Report

American Journal of Kidney Diseases

Volumn 53, Issue 3, 2009, Pages 492-502

  Abbas, Saib A ^a   Haloob, Imad A ^b   Taylor, Susan L ^a   Curry, Elizabeth M ^a   King, Bruce B ^c   Van der Merwe, Walter M ^d   Marshall, Mark R ^a  

^a MIDDLEMORE HOSPITAL   (New Zealand)

^b TAURANGA HOSPITAL   (New Zealand)

^c NELSON HOSPITAL   (New Zealand)

^d WHANGAREI HOSPITAL   (New Zealand)

Author keywords

antimicrobial locks; bacterial resistance; bloodstream infection; dialysis catheters; Hemodialysis

Indexed keywords

GENTAMICIN; HEPARIN; METICILLIN; QUINOLONE;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; BLOODSTREAM INFECTION; CATHETER INFECTION; CATHETER REMOVAL; COAGULASE NEGATIVE STAPHYLOCOCCUS; CROSS-SECTIONAL STUDY; DESCRIPTIVE RESEARCH; DIALYSIS CATHETER; ENTEROBACTERIACEAE; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NEW ZEALAND; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; TIME SERIES ANALYSIS;

AGED; ANTI-BACTERIAL AGENTS; CATHETER-RELATED INFECTIONS; CATHETERS, INDWELLING; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, BACTERIAL; EQUIPMENT DESIGN; FEMALE; GENTAMICINS; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS; SEPSIS;

EID: 60349106408     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.09.019     Document Type: Article

References (71)

1. Burr R., Marszalek J., Saul M., Shields M., and Aslam N. The cost of vascular access infections: Three years experience from a single outpatient dialysis center. Hemodial Int 7 (2003) 73-104
2. Liu J.W., Su Y.K., Liu C.F., and Chen J.B. Nosocomial blood-stream infection in patients with end-stage renal disease: Excess length of hospital stay, extra cost and attributable mortality. J Hosp Infect 50 (2002) 224-227
3. Polkinghorne K.R., McDonald S.P., Atkins R.C., and Kerr P.G. Vascular access and all-cause mortality: A propensity score analysis. J Am Soc Nephrol 15 (2004) 477-486
4. Pastan S., Soucie J.M., and McClellan W.M. Vascular access and increased risk of death among hemodialysis patients. Kidney Int 62 (2002) 620-626
5. Ishani A., Collins A.J., Herzog C.A., and Foley R.N. Septicemia, access and cardiovascular disease in dialysis patients: The USRDS Wave 2 Study. Kidney Int 68 (2005) 311-318
6. Schwab S.J., and Beathard G. The hemodialysis catheter conundrum: Hate living with them, but can't live without them. Kidney Int 56 (1999) 1-17
7. Centers for Disease Control and Prevention. Guidelines for the prevention of intravascular catheter-related infections. MMWR Morbid Mortal Wkly Rep 51(No. RR-10) 28 (2002)
8. Lok C.E. Avoiding trouble down the line: The management and prevention of hemodialysis catheter-related infections. Adv Chronic Kidney Dis 13 (2006) 225-244
9. Manierski C., and Besarab A. Antimicrobial locks: Putting the lock on catheter infections. Adv Chronic Kidney Dis 13 (2006) 245-258
10. Bleyer A.J. Use of antimicrobial catheter lock solutions to prevent catheter-related bacteremia. Clin J Am Soc Nephrol 2 (2007) 1073-1078
11. Dogra G., Herson H., Hutchison B., et al. Prevention of tunnelled hemodialysis catheter related infections using catheter-restricted filling with gentamicin and citrate: A randomized controlled study. J Am Soc Nephrol 13 (2002) 2133-2139
12. Sodemann K., Polaschegg H., and Feldmer B. Two years' experience with Dialock and CLS (a new antimicrobial lock solution). Blood Purif 19 (2001) 251-254
13. Vercaigne L.M., Sitar D.S., Penner S.B., Bernstein K., Wang G.Q., and Burczynski F.J. Antibiotic-heparin lock: In vitro antibiotic stability combined with heparin in a central venous catheter. Pharmacotherapy 20 (2000) 394-399
14. Riley B. Incompatibilities in intravenous solutions. J Hosp Pharm 28 (1970) 228-240
15. Trissel L. Handbook on Injectable Drugs (2003), American Society of Health-System Pharmacists, Bethesda, MD
16. Bastani B., Amin K., and Herr A. Prolonged stability of stored vancomycin, gentamicin, and heparin for use in the antibiotic-lock technique. ASAIO J 51 (2005) 761-763
17. Regamey C., Schaberg D., and Kirby W.M. Inhibitory effect of heparin on gentamicin concentrations in blood. Antimicrob Agents Chemother 1 (1972) 329-332
18. Krishnasami Z., Carlton D., Bimbo L., et al. Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. Kidney Int 61 (2002) 1136-1142
19. Saxena A., Panhotra B., and Naguib M. Sudden irreversible sensory-neural hearing loss in a patient with diabetes receiving amikacin as an antibiotic-heparin lock. Pharmacotherapy 22 (2002) 105-108
20. Dogra G., White L., Herson H., et al. Prevention of tunneled hemodialysis catheter-related infections using low concentration gentamicin and citrate. Nephrology (Carlton) 9 suppl 1 (2004) S13A abstr
21. Kim S.H., Song K.I., Chang J.W., et al. Prevention of uncuffed hemodialysis catheter-related bacteremia using an antibiotic lock technique: A prospective, randomized clinical trial. Kidney Int 69 (2006) 161-164
22. McIntyre C.W., Hulme L.J., Taal M., and Fluck R.J. Locking of tunneled hemodialysis catheters with gentamicin and heparin. Kidney Int 66 (2004) 801-805
23. Feely T., Copley A., and Bleyer A.J. Catheter lock solutions to prevent bloodstream infections in high-risk hemodialysis patients. Am J Nephrol 27 (2007) 24-29
24. Allon M. Dialysis catheter-related bacteremia: Treatment and prophylaxis. Am J Kidney Dis 44 (2004) 779-791
25. Dogra G. Preventing catheter-related infections with antibiotic lock solutions: Are we spoilt for choice?. Nephrology (Carlton) 11 (2006) 297-298
26. Brown H., and Prescott R. Applied Mixed Models in Medicine (1999), Wiley, Chichester, England
27. Hsaio C. Analysis of Panel Data (2003), Cambridge University, Cambridge, UK
28. Rabe-Hesketh S., and Skrondal A. Multilevel and Longitudinal Modeling Using Stata (2005), Stata Press, College Station, TX
29. Raad I., Costerton W., Sabharwal U., Sacilowski M., Anaissie E., and Bodey G.P. Ultrastructural analysis of indwelling vascular catheters: A quantitative relationship between luminal colonization and duration of placement. J Infect Dis 168 (1993) 400-407
30. Dittmer I.D., Sharp D., McNulty C.A., Williams A.J., and Banks R.A. A prospective study of central venous hemodialysis catheter colonization and peripheral bacteremia. Clin Nephrol 51 (1999) 34-39
31. Rosett W., and Hodges G.R. Antimicrobial activity of heparin. J Clin Microbiol 11 (1980) 30-34
32. Shah C.B., Mittelman M.W., Costerton J.W., et al. Antimicrobial activity of a novel catheter lock solution. Antimicrob Agents Chemother 46 (2002) 1674-1679
33. Percival S.L., Kite P., Eastwood K., et al. Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm. Infect Control Hosp Epidemiol 26 (2005) 515-519
34. Shanks R.M., Sargent J.L., Martinez R.M., Graber M.L., and O'Toole G.A. Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces. Nephrol Dial Transplant 21 (2006) 2247-2255
35. Nori U.S., Manoharan A., Yee J., and Besarab A. Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia. Am J Kidney Dis 48 (2006) 596-605
36. Allon M. Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution. Clin Infect Dis 36 (2003) 1539-1544
37. Shanks R.M., Donegan N.P., Graber M.L., et al. Heparin stimulates Staphylococcus aureus biofilm formation. Infect Immun 73 (2005) 4596-4606
38. Jaffer Y., Selby N., Taal M., Fluck R., and McIntyre C.W. A meta-analysis of haemodialysis catheter locking solutions in the prevention of catheter related infection. Am J Kdney Dis 51 (2008) 233-241
39. Labriola L., Crott R., and Jadoul M. Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: A meta-analysis of prospective randomized trials. Nephrol Dial Transplant 23 (2007) 1666-1672
40. Weijmer M.C., van den Dorpel M.A., Van de Ven P.J., et al. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J Am Soc Nephrol 16 (2005) 2769-2777
41. Betjes M.G., and van Agteren M. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Nephrol Dial Transplant 19 (2004) 1546-1551
42. Pervez A., Ahmed M., Ram S., et al. Antibiotic lock technique for prevention of cuffed tunnel catheter associated bacteremia. J Vasc Access 3 (2002) 108-113
43. Saxena A.K., Panhotra B.R., Sundaram D.S., et al. Tunneled catheters' outcome optimization among diabetics on dialysis through antibiotic-lock placement. Kidney Int 70 (2006) 1629-1635
44. Geron R., Tanchilevski O., and Kristal B. [Catheter lock solution-Taurolock for prevention of catheter-related bacteremia in hemodialysis patients]. Harefuah 145 (2006) 881-884 943
45. Lambie S.H., Hulme L.J., Taal M., Fluck R.J., and McIntyre C.W. Prospective study of gentamicin locking of tunnelled dialysis catheters: The effect on infection rates and CRP. Kidney Int 67 (2005) 378
46. Bleyer A.J., Mason L., Russell G., Raad I.I., and Sherertz R.J. A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access. Infect Control Hosp Epidemiol 26 (2005) 520-524
47. Duncan N., Singh S., Amao M., et al. A single centre randomised control trial of sodium citrate versus heparin line locks for cuffed central venous catheters. J Am Soc Nephrol 16 (2007) 451A (abstr)
48. D'Avella J., Li L., Qamar A., McDaniel A., Robbins K., and Cooper B. A randomized trial of hypertonic saline and heparin lock solution in the prevention of hemodialysis catheter related bacteremia. J Am Soc Nephrol 18 (2007) 461A (abstr)
49. Winnett G., Nolan J., Millar M., and Ashman N. Trisodium citrate (TSC) selectively reduces staphylococcal catheter related bacteriaemia (CRB). J Am Soc Nephrol 18 (2007) 460A (abstr)
50. Zhang P., Zhang W., He Q., et al. A randomized controlled study on prevention of cuff-tunneled catheter related bacteremia with gentamicin-heparin lock solution: The metaphase result. J Am Soc Nephrol 17 (2007) 592A (abstr)
51. Ash S., Mankus R., Sutton J., et al. Concentrated sodium citrate (23%) for catheter lock. Hemodial Int 4 (2000) 22-31
52. Saxena A.K., Panhotra B.R., Sundaram D.S., Morsy M.N., and Al-Ghamdi A.M. Enhancing the survival of tunneled haemodialysis catheters using an antibiotic lock in the elderly: A randomised, double-blind clinical trial. Nephrology (Carlton) 11 (2006) 299-305
53. Fluck R.J., McIntyre C.W., and Taal M. A one-year experience single center with antibiotic locking for tunneled venous catheters. J Am Soc Nephrol 17 (2006) 591A (abstr)
54. Klevens R.M., Tokars J.I., and Andrus M. Electronic reporting of infections associated with hemodialysis. Nephrol News Issues 19 (2005) 37-38 43
55. Blankestijn P.J. Treatment and prevention of catheter-related infections in haemodialysis patients. Nephrol Dial Transplant 16 (2001) 1975-1978
56. Beathard G.A. Catheter management protocol for catheter-related bacteremia prophylaxis. Semin Dial 16 (2003) 403-405
57. Katneni R., and Hedayati S.S. Central venous catheter-related bacteremia in chronic hemodialysis patients: Epidemiology and evidence-based management. Nat Clin Pract Nephrol 3 (2007) 256-266
58. Alexandraki I., Bhatt U., Plott D., and Nakman Jr. N. Hemodialysis vascular catheter-related bacteremia: Five year epidemiological shift in organism isolates. J Am Soc Nephrol 16 (2005) 453A (abstr)
59. Danese M.D., Griffiths R.I., Dylan M., Yu H.T., Dubois R., and Nissenson A.R. Mortality differences among organisms causing septicemia in hemodialysis patients. Hemodial Int 10 (2006) 56-62
60. D'Agata E.M. Antimicrobial-resistant, gram-positive bacteria among patients undergoing chronic hemodialysis. Clin Infect Dis 35 (2002) 1212-1218
61. Taal M., Fluck R., and McIntyre C. Preventing catheter related infections in haemodialysis patients. Curr Opin Nephrol Hypertens 15 (2006) 599-602
62. Guerraoui A., Dacosta E., Roche B., et al. Emergence of multiresistant Staphylococcus epidermidis (MRSE) after lock antibiotic regimen by gentamicin in permanent hemodialysis catheters. Prospective study 1999-2003. J Am Soc Nephrol 15 (2004) 368A (abstr)
63. Finger F., Rossaak M., Umstaetter R., Reulbach U., and Pitto R. Skin infections of the limbs of Polynesian children. N Z Med J 117 (2004) U847
64. Chambers S., Laing R., Murdoch D., et al. Maori have a much higher incidence of community-acquired pneumonia and pneumococcal pneumonia than non-Maori: Findings from two New Zealand hospitals. N Z Med J 119 (2006) U1978
65. Tiu A., Martin R., Vanniasingham P., MacCormick A.D., and Hill A.G. Necrotizing fasciitis: Analysis of 48 cases in South Auckland, New Zealand. ANZ J Surg 75 (2005) 32-34
66. Lawton B., Rose S., Bromhead C., Brown S., MacDonald J., and Shepherd J. Rates of Chlamydia trachomatis testing and chlamydial infection in pregnant women. N Z Med J 117 (2004) U889
67. Weir R.P., Brunton C.R., and Blakely T.A. Chronic liver disease mortality attributable to hepatitis B and C in New Zealand. J Gastroenterol Hepatol 17 (2002) 582-588
68. Wilson N., Baker M., Martin D., et al. Meningococcal disease epidemiology and control in New Zealand. N Z Med J 108 (1995) 437-442
69. Ellison-Loschmann L., and Pearce N. Improving access to health care among New Zealand's Maori population. Am J Public Health 96 (2006) 612-617
70. Yang L.P., Eriksson B.K., Harrington Z., et al. Variations in the protective immune response against streptococcal superantigens in populations of different ethnicity. Med Microbiol Immunol 195 (2006) 37-43
71. Conley J., James M., MacRae J., et al. Antimicrobial agents for the prophylaxis of catheter related bloodstream infections in hemodialysis patients: A systematic review and meta-analysis. J Am Soc Nephrol 18 (2007) 463A (abstr)